Category: St. Jude Medical
Wall Street investors send shares of St. Jude Medical up yesterday and down today after the company reveals a warning letter from the FDA over its Sylmar, Calif., Durata defibrillator lead plant.
A warning letter from the FDA to St. Jude Medical (NYSE:STJ) sent the St. Paul, Minn.-based medical device company's stock on a seesaw ride yesterday and today.
STJ shares closed up 1.5% yesterday at $38.85 each after St. Jude revealed the warning letter, but closed down 1.2% today at $38.39 apiece.
St. Jude Medical says the FDA hit it with a warning letter last week over problems at the Sylmar, Calif., plant that makes its next-generation Durata defibrillator leads.
St. Jude Medical (NYSE:STJ) said today that the FDA slapped it with a warning letter over problems with the Sylmar, Calif., plant where its keystone Durata defibrillator leads are manufactured.
St. Jude Medical CEO Daniel Starks says the FDA's warnings of manufacturing deficiencies at a California plant are unrelated to the safety and reliability of the Durata defibrillator leads that are made there.
St. Jude Medical's (NYSE:STJ) implanted cardiac device market share is in great shape despite ongoing issues with its high-voltage defibrillator leads, CEO Daniel Starks told an audience at the J.P. Morgan healthcare conference last night.
St. Jude Medical admits to quality control problems at the plant that makes its Durata defibrillator leads in a letter to the FDA reviewed by the Wall Street Journal and says it's putting procedures in place to remedy the issues.
St. Jude Medical (NYSE:STJ) copped to quality control problems at the Sylmar, Calif., plant that makes its next-generation Durata defibrillator leads, saying it's put measures in place to remedy the issues.
Boston Scientific CFO Jeffrey Capello says the medical device giant is looking to capitalize on the reliability of its ICD leads, especially in light of the "challenges" faced by an ICD competitor.
Boston Scientific (NYSE:BSX) is looking for ways to leverage its product pipeline in 2013, part of which may include capitalizing on some of the "challenges" facing one of their biggest rivals.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of 2012.
The medical device industry was full of big stories in 2012, ranging from efforts to bring down the device tax and related layoffs to epic public face-offs between industry leaders.
St. Jude and AorTech International come to a manufacture and supply agreement after St. Jude wins an injunction preventing termination of their contract.
